Louis Kirby

Louis Kirby, MD, has extensive experience in the pharmaceutical and medical fields, currently serving as a book author for Shadow of Eden since 2013 and a co-founder of ZettaScience since 2011. As a consultant and medical director at Neuraltus Pharmaceuticals, Kirby oversees the clinical development of medications targeting ALS and Parkinson's disease. Past roles include serving as a medical monitor and responsible medical officer at vTv Therapeutics, where Kirby was involved in a large Alzheimer's trial, and as a medical director for Amarantus BioScience, focusing on the LymPro test for Alzheimer's. A co-founder and former CEO of MigraTherapy, Kirby has also led initiatives at the Critical Path Institute to qualify biomarkers for major diseases. Additionally, Kirby founded Pivotal Research Centers, establishing it as a leading entity in the industry before transitioning to a medical directorship following its acquisition. Academic credentials include an MD from The University of Texas Medical Branch and a BA from The University of Texas at Austin.